Light Mode
$0.0048 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0048, and at the day’s high of $0.0058
-0.03 (-85.00%) / 6M
Momentum, market sentiment, and recent alerts
CERO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -99.7%.
No alerts for CERO in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in South San Francisco, CA.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.